Asahi Glass and Japan Material Technologies Corp. (JMTC; Tokyo) on Tuesday announced the establishment of a joint venture company, JMTC Enzyme, which aims to commercialize biochemical technologies that produce organic acids, such as lactic acid, from biomass.
JMTC has 92% in the new company and Asahi Glass 8%.
JMTC Enzyme will commercialize the technologies by acquiring part of the intellectual property for organic acid production based on Schizosaccharomyces pombe developed by Asahi Glass and by using engineers seconded from Asahi Glass.
In addition, the new company will proceed with commercializing D-lactic acid, for which Asahi Glass has already completed basic development, as well as continuously develop other organic acid production technologies.
By Natasha Alperowicz
Source: Chemical Week
This equipment will significantly lower the site’s CO2 emissions, reduce flaring and save around 60 gigawatt hours (GWh) energy each year. Project kick-off is in February 2021, with completion planned for 2023.
The acquisition significantly strengthens and expands Grace’s existing pharma portfolio. Pharma & Consumer is the largest, fastest growing and most profitable subsegment within Grace’s Materials Technologies business.
Solvay says it has decided to organize its soda ash and derivatives business into a separate and fully controlled legal structure.
